Zyprexa Intramuscular en es it fr


Zyprexa Intramuscular Les marques, Zyprexa Intramuscular Analogs

Zyprexa Intramuscular Les marques melange

  • No information avaliable
  • Zyprexa Intramuscular Formule chimique


    Zyprexa Intramuscular RX lien


    Zyprexa Intramuscular FDA fiche

    Zyprexa_Intramuscular FDA

    Zyprexa Intramuscular msds (fiche de securite des materiaux)

    Zyprexa Intramuscular Synthese de reference

    JK Chakrabarti et al., US. 5,229,382 (1991)

    Zyprexa Intramuscular Poids moleculaire

    312.434 g/mol

    Zyprexa Intramuscular Point de fusion


    Zyprexa Intramuscular H2O Solubilite

    Aucune information disponible

    Zyprexa Intramuscular Etat


    Zyprexa Intramuscular LogP


    Zyprexa Intramuscular Formes pharmaceutiques

    Tablet (oral)

    Zyprexa Intramuscular Indication

    Pour le traitement de la schizophrénie et la maniaco-dépression (trouble bipolaire).

    Zyprexa Intramuscular Pharmacologie

    L'olanzapine, un antipsychotique atypique, est utilisé pour traiter les symptômes positifs et négatifs de la schizophrénie, la manie aiguë avec le trouble bipolaire, l'agitation et des symptômes psychotiques dans la démence. Futur utilisations peuvent inclure le traitement du trouble obsessionnel-compulsif et troubles graves du comportement dans l'autisme. Structurellement et pharmacologique similaire à la clozapine, l'olanzapine se lie à l'alpha (1), la dopamine, , L'histamine H1, muscariniques, et 2 de type sérotonine (5-HT2) récepteurs.

    Zyprexa Intramuscular Absorption

    Eh bien absorbé, avec environ 40% de la dose métabolisée avant d'atteindre la circulation systémique.

    Zyprexa Intramuscular Toxicite

    Aucune information disponible

    Zyprexa Intramuscular Information pour les patients


    Physicians are advised to discuss the following issues with patients for whom they prescribe

    Orthostatic Hypotension: Patients should be advised of the risk of orthostatic hypotension,
    especially during the period of initial dose titration and in association with the use of
    concomitant drugs that may potentiate the orthostatic effect of olanzapine, e.g., diazepam
    or alcohol.

    Interference with Cognitive and Motor Performance: Because olanzapine has the potential to
    impair judgment, thinking, or motor skills, patients should be cautioned about operating
    hazardous machinery, including automobiles, until they are reasonably certain that olanzapine
    therapy does not affect them adversely.

    Pregnancy: Patients should be advised to notify their physician if they become pregnant or
    intend to become pregnant during therapy with olanzapine.

    Nursing: Patients should be advised not to breast-feed an infant if they are taking olanzapine.

    Concomitant Medication: Patients should be advised to inform their physicians if they are taking,
    or plan to take, any prescription or over-the-counter drugs, since there is a potential for

    Alcohol: Patients should be advised to avoid alcohol while taking olanzapine.

    Heat Exposure and Dehydration: Patients should be advised regarding appropriate care in avoiding
    overheating and dehydration.

    Phenylketonurics: ZYPREXA ZYDIS (olanzapine orally disintegrating tablets) contains phenylalanine
    (0.34, 0.45, 0.67, or 0.90 mg per 5, 10, 15, or 20mg tablet, respectively).

    Laboratory Tests

    Periodic assessment of transaminases is recommended in patients with significant hepatic disease.

    Zyprexa Intramuscular Organismes affectes

    Les humains et autres mammifères